Abstracts

EVALUATION OF CAB-LA SAFETY AND PK IN PREGNANT WOMEN IN THE BLINDED PHASE OF HPTN 084

HPTN 084 is a phase 3 randomized, double-blind, double-dummy trial that showed that long-acting injectable cabotegravir (CAB-LA) was superior to tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in preventing HIV in women in sub-Saharan Africa. Participants were required to use long-acting contraception; however, pregnancies occurred during the trial. We report on the safety and pharmacokinetics of CAB-LA in…

PREGNANCY IN WOMEN WITH HIV IN A TUBERCULOSIS-PREVENTIVE THERAPY TRIAL

Tuberculosis (TB) during pregnancy in women with HIV infection is associated with both poor maternal and child outcomes. TB preventive therapy (TPT) is recommended for people with HIV infection, including during pregnancy. However, the impact of TPT exposure at conception and during pregnancy is poorly documented. We report pregnancy outcomes among South African women with…

PrEP CONTINUATION AND OBJECTIVE ADHERENCE IN PREGNANT/POSTPARTUM SOUTH AFRICAN WOMEN

Effective oral pre-exposure prophylaxis (PrEP) requires daily adherence but little is known about objective levels of adherence during pregnancy and postpartum. We enrolled consenting pregnant, HIV-uninfected cisgender women at first antenatal care (ANC) visit with follow-up through 12-months postpartum. Women and girls >15-yrs who were eligible for the study received HIV prevention counseling and were…